Literature DB >> 31775051

In Vivo Protein Complementation Demonstrates Presynaptic α-Synuclein Oligomerization and Age-Dependent Accumulation of 8-16-mer Oligomer Species.

Martin Kiechle1, Bjoern von Einem1, Lennart Höfs2, Patrizia Voehringer3, Veselin Grozdanov1, Daniel Markx4, Rosanna Parlato5, Diana Wiesner1, Benjamin Mayer6, Olena Sakk7, Bernd Baumann7, Soeren Lukassen8, Birgit Liss9, Arif B Ekici8, Albert C Ludolph1, Paul Walther10, Boris Ferger3, Pamela J McLean11, Björn H Falkenburger2, Jochen H Weishaupt1, Karin M Danzer12.   

Abstract

Intracellular accumulation of α-synuclein (α-syn) and formation of Lewy bodies are neuropathological characteristics of Parkinson's disease (PD) and related α-synucleinopathies. Oligomerization and spreading of α-syn from neuron to neuron have been suggested as key events contributing to the progression of PD. To directly visualize and characterize α-syn oligomerization and spreading in vivo, we generated two independent conditional transgenic mouse models based on α-syn protein complementation assays using neuron-specifically expressed split Gaussia luciferase or split Venus yellow fluorescent protein (YFP). These transgenic mice allow direct assessment of the quantity and subcellular distribution of α-syn oligomers in vivo. Using these mouse models, we demonstrate an age-dependent accumulation of a specific subtype of α-syn oligomers. We provide in vivo evidence that, although α-syn is found throughout neurons, α-syn oligomerization takes place at the presynapse. Furthermore, our mouse models provide strong evidence for a transsynaptic cell-to-cell transfer of de novo generated α-syn oligomers in vivo.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Parkinson's disease; aging; alpha-synuclein; neurodegeneration; oligomerization; progressive phenotype; protein-fragment complementation; spreading; synaptic oligomers; transgenic mouse model

Mesh:

Substances:

Year:  2019        PMID: 31775051     DOI: 10.1016/j.celrep.2019.10.089

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  9 in total

1.  LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons.

Authors:  Kevin Burbidge; David J Rademacher; Jessica Mattick; Stephanie Zack; Andrea Grillini; Luc Bousset; Ochan Kwon; Konrad Kubicki; Alexander Simon; Ronald Melki; Edward M Campbell
Journal:  Autophagy       Date:  2021-10-06       Impact factor: 13.391

2.  Differential Regional Responses in Soluble Monomeric Alpha Synuclein Abundance Following Traumatic Brain Injury.

Authors:  S W Carlson; H Q Yan; Y Li; J Henchir; X Ma; M S Young; M D Ikonomovic; C E Dixon
Journal:  Mol Neurobiol       Date:  2020-09-19       Impact factor: 5.590

Review 3.  Anti-aggregation Effects of Phenolic Compounds on α-synuclein.

Authors:  Kenjiro Ono; Mayumi Tsuji; Tritia R Yamasaki; Giulio M Pasinetti
Journal:  Molecules       Date:  2020-05-24       Impact factor: 4.411

Review 4.  Intracellular Alpha-Synuclein and Immune Cell Function.

Authors:  Veselin Grozdanov; Karin M Danzer
Journal:  Front Cell Dev Biol       Date:  2020-10-15

Review 5.  Soluble endogenous oligomeric α-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk.

Authors:  Rakez Kayed; Ulf Dettmer; Sylvain E Lesné
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

6.  Impact of α-synuclein spreading on the nigrostriatal dopaminergic pathway depends on the onset of the pathology.

Authors:  Fanfan Sun; Armando G Salinas; Severin Filser; Sonja Blumenstock; Jose Medina-Luque; Jochen Herms; Carmelo Sgobio
Journal:  Brain Pathol       Date:  2021-11-21       Impact factor: 6.508

7.  CK1BP Reduces α-Synuclein Oligomerization and Aggregation Independent of Serine 129 Phosphorylation.

Authors:  Lea Elsholz; Yasmine Wasser; Patrick Ziegler; Pardes Habib; Aaron Voigt
Journal:  Cells       Date:  2021-10-21       Impact factor: 7.666

8.  Monitoring the interactions between alpha-synuclein and Tau in vitro and in vivo using bimolecular fluorescence complementation.

Authors:  Laura Torres-Garcia; Joana M P Domingues; Edoardo Brandi; Caroline Haikal; Janitha M Mudannayake; Inês C Brás; Ellen Gerhardt; Wen Li; Alexander Svanbergsson; Tiago F Outeiro; Gunnar K Gouras; Jia-Yi Li
Journal:  Sci Rep       Date:  2022-02-22       Impact factor: 4.379

Review 9.  The Role of α-Synuclein Oligomers in Parkinson's Disease.

Authors:  Xiao-Yu Du; Xi-Xiu Xie; Rui-Tian Liu
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.